Project
Efficacy and safety comparison of brodalumab versus guselkumab in adult subjects with moderate -to -severe plaque psoriasis and inadequate response to ustekinumab; COBRA / Phase 4 – efficacy trial A randomised, blinded, parallel-group, multi-site, clinical trial
Completed - recruitment active · 2021 until 2022
Cozzio Antonio
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed - recruitment active
Start Date
2021
End Date
2022
Financing
Industry